BackUnidoc Health Overview

Unidoc Health EBIT

Track Unidoc Health's EBIT ($-2.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$508.45K
↑ 20.62% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$2.92M
↑ 37.88% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Unidoc Health (UDOCF) FAQ

The latest EBIT for UDOCF is $-2.9M as of June 2026. That compares with $-4.7M in the prior-year period — up 37.9% year over year. That is below the sector sector average of $2.3T. Investors often review this figure alongside Unidoc Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, UDOCF's EBIT moved from $-4.7M to $-2.9M — a 37.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Unidoc Health's operating scale or balance-sheet position.

Against its sector companies, UDOCF currently prints $-2.9M for EBIT, while the sector average sits near $2.3T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Unidoc Health's growth, margins, and balance sheet.

A EBIT figure of $-2.9M for UDOCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.3T. Explore the charts below for those layers of context.

After noting UDOCF's EBIT ($-2.9M), review year-over-year change from $-4.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers